Peter Parker
Founder at Piramed Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sarah Whitney | F | 60 |
University College London
| - |
Stephane Jallat | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 years |
Michael D. Waterfield | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 years |
Paul Workman | M | 72 |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 years |
Mark P. Richmond | M | 92 |
University College London
| - |
David Attwell | M | - |
University College London
| - |
Amit Chunilal Nathwani | M | 64 |
University College London
| 13 years |
Sergio Quezada | M | 49 |
University College London
| 13 years |
Josephine Clare Baroness Valentine | F | 66 |
University College London
| - |
Mark Lowdell | M | 61 |
University College London
| 30 years |
Mariana Mazzucato | M | 56 |
University College London
| 7 years |
Julia Prescot | F | 65 |
University College London
| - |
Christopher Mason | M | 66 |
University College London
| 25 years |
Saladin Meckled-Garcia | M | - |
University College London
| - |
Ven Balakrishnan | M | - |
University College London
| - |
Katharine Roseveare | F | - |
University College London
| - |
Nick McGhee | M | - |
University College London
| - |
Maria Wyke | F | - |
University College London
| - |
Stephanie Schorge | M | - |
University College London
| - |
Ian Dato | M | 46 |
University College London
| - |
Mark Sudbury | M | - |
University College London
| - |
Clare Goudy | F | - |
University College London
| - |
Nigel Waugh | M | - |
University College London
| - |
Paul Ayris | M | - |
University College London
| - |
Peter Cadley | M | - |
University College London
| - |
Wendy Appleby | F | - |
University College London
| - |
Magnus Nyden | M | - |
University College London
| - |
Mark Miodownik | M | - |
University College London
| - |
Claire Callender | F | - |
University College London
| - |
Shervanthi Homer-Vanniasinkam | M | 65 |
University College London
| - |
Junaid Bajwa | M | 45 |
University College London
| - |
Kai Kit Wong | M | 50 |
University College London
| 9 years |
Derek Lionel Glendon Hill | M | 58 |
University College London
| 29 years |
Mark Emberton | M | - |
University College London
| - |
Vanessa Lawrence | M | - |
University College London
| - |
Roy Quilliam | M | 63 |
University College London
| - |
José-Alain Sahel | M | 68 |
University College London
| - |
Michael Pepper | M | - |
University College London
| 15 years |
Stanton Peter Newman | M | 75 |
University College London
| - |
John Reid | M | 77 |
University College London
| - |
John Marshall | M | 80 |
University College London
| - |
David Knox | M | 66 |
University College London
| - |
Adele Biss | F | - |
University College London
| - |
Simon Long | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
William Rosenberg | M | - |
University College London
| - |
Dame Angela Strank | M | 71 |
University College London
| - |
John Collinge | M | 66 |
University College London
| - |
Ted Dinan | M | - |
University College London
| - |
John W. Martin | M | - |
University College London
| - |
Matt Harvey | M | - |
University College London
| - |
David Delpy | M | - |
University College London
| 25 years |
Quentin Pankhurst | M | - |
University College London
| - |
Michael Arthur | M | - |
University College London
| 11 years |
Derralynn Hughes | F | - |
University College London
| - |
Dominic Blakemore | M | 54 |
University College London
| - |
Chris Russell | M | - |
University College London
| - |
DeAnne Shirley Julius | M | 75 |
University College London
| 10 years |
Melissa Terras | F | - |
University College London
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael G. Moore | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 5 years |
David B. Knowles | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
Stephen Shuttleworth | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 3 years |
Neil Pegg | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
Anthony Brown | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Parker
- Personal Network